Agilent shares surged 17% from $115.79 to $135.42 on Thursday, the first trading day after the firm announced better-than-expected results for the second quarter of fiscal year 2026, ended April 30. The stock's single-day leap marked its strongest performance since November 19, 2002, when it rose 16% to $134.50.
The revenue and earnings beat, reported by the tools giant after market close Wednesday, drove the sharp rally. The company operates on a fiscal year ending October 31. Specific quarterly figures beyond the stock price movement were not detailed in the available report.
This is the first trading session since the earnings release, and the double-digit percentage gain underscores investor enthusiasm for Agilent's operational execution during a challenging period for the life sciences tools sector. The stock closed at $135.42, up from the prior day's close of $115.79.
Competitors in the analytical and life sciences instrumentation space have faced headwinds from macroeconomic uncertainty and reduced capital spending by biopharma customers. Agilent's ability to exceed consensus estimates may signal a potential turnaround in end-market demand.
No additional financial details, such as adjusted earnings per share or revenue figures, were provided in the source material. The brief is based solely on the reported stock movement and the company's fiscal calendar.